CD8A and melanoma: This might be of particular relevance as we recently reported the early disappearance of functional Melan-A- or NY-ESO-1-reactive CD4+ and/or CD8+ T cells from the peripheral blood in some melanoma patients with superior OS and PFS under PD-1 ICB resulting from a hypothetical migration to the metastases (25).